Health Economic Benefits of Implementing Nucleic Acid Testing in Addition To Serology for Blood Transfusion Safety in India: a Cost-Effectiveness Analysis.

Jindal DK, Sarmah MD, Sewlikar S, Wadia K

Open source

DOI
10.1007/s12288-025-02235-0
Published
2026 Sep
Container
Indian journal of hematology & blood transfusion : an official journal of Indian Society of Hematology and Blood Transfusion
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1007/s12288-025-02235-0,
  title = {Health Economic Benefits of Implementing Nucleic Acid Testing in Addition To Serology for Blood Transfusion Safety in India: a Cost-Effectiveness Analysis.},
  author = {Jindal DK and Sarmah MD and Sewlikar S and Wadia K},
  year = {2026},
  journal = {Indian journal of hematology \& blood transfusion : an official journal of Indian Society of Hematology and Blood Transfusion},
  doi = {10.1007/s12288-025-02235-0},
  url = {https://doi.org/10.1007/s12288-025-02235-0}
}

RIS

TY  - JOUR
TI  - Health Economic Benefits of Implementing Nucleic Acid Testing in Addition To Serology for Blood Transfusion Safety in India: a Cost-Effectiveness Analysis.
AU  - Jindal DK
AU  - Sarmah MD
AU  - Sewlikar S
AU  - Wadia K
PY  - 2026
JO  - Indian journal of hematology & blood transfusion : an official journal of Indian Society of Hematology and Blood Transfusion
DO  - 10.1007/s12288-025-02235-0
UR  - https://doi.org/10.1007/s12288-025-02235-0
ER  - 

APA

DK, J., MD, S., S, S., & K, W. (2026). Health Economic Benefits of Implementing Nucleic Acid Testing in Addition To Serology for Blood Transfusion Safety in India: a Cost-Effectiveness Analysis.. Indian journal of hematology & blood transfusion : an official journal of Indian Society of Hematology and Blood Transfusion. https://doi.org/10.1007/s12288-025-02235-0

Source records